Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune response to sipuleucel-T in prostate cancer.
Thara E, Dorff TB, Averia-Suboc M, Luther M, Reed ME, Pinski JK, Quinn DI. Thara E, et al. Among authors: quinn di. Cancers (Basel). 2012 Apr 18;4(2):420-41. doi: 10.3390/cancers4020420. Cancers (Basel). 2012. PMID: 24213318 Free PMC article.
Small cell bladder cancer: biology and management.
Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB. Fahed E, et al. Among authors: quinn di. Semin Oncol. 2012 Oct;39(5):615-8. doi: 10.1053/j.seminoncol.2012.08.009. Semin Oncol. 2012. PMID: 23040258 Review.
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
Quinn DI, Tangen CM, Hussain M, Lara PN Jr, Goldkorn A, Moinpour CM, Garzotto MG, Mack PC, Carducci MA, Monk JP, Twardowski PW, Van Veldhuizen PJ, Agarwal N, Higano CS, Vogelzang NJ, Thompson IM Jr. Quinn DI, et al. Lancet Oncol. 2013 Aug;14(9):893-900. doi: 10.1016/S1470-2045(13)70294-8. Epub 2013 Jul 17. Lancet Oncol. 2013. PMID: 23871417 Free PMC article. Clinical Trial.
Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors.
Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. Piatek CI, et al. Among authors: quinn di. Cancer Chemother Pharmacol. 2014 Dec;74(6):1227-34. doi: 10.1007/s00280-014-2600-z. Epub 2014 Nov 6. Cancer Chemother Pharmacol. 2014. PMID: 25374407 Clinical Trial.
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer.
Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN Jr, Van Veldhuizen PJ Jr, Quinn DI, Vogelzang NJ, Thompson IM Jr, Hussain MH. Dorff TB, et al. Among authors: quinn di. Clin Cancer Res. 2010 Jun 1;16(11):3028-34. doi: 10.1158/1078-0432.CCR-09-3122. Epub 2010 May 18. Clin Cancer Res. 2010. PMID: 20484019 Free PMC article. Clinical Trial.
EphB4 expression and biological significance in prostate cancer.
Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. Xia G, et al. Among authors: quinn di. Cancer Res. 2005 Jun 1;65(11):4623-32. doi: 10.1158/0008-5472.CAN-04-2667. Cancer Res. 2005. PMID: 15930280
272 results